FDA Offers Clues, But No Clear Standards, On "Breakthrough"-Worthiness

Although officials say “breakthrough therapies” are “transformative” treatments that “hit you in the face” with their efficacy, the agency has yet to release clear guidelines to help industry determine when a product is worthy of the coveted designation.

More from Archive

More from In Vivo